eCARTv5 Clinical Deterioration Suite (“eCART”) vs UpDoc Inc.

AgileMD's eCART is praised for its highly intuitive user interface and seamless integration with EHRs, which minimizes disruption and streamlines workflows. Users consistently highlight its user-friendly design and reliable performance. In contrast, while UpDoc is noted for convenience, some user reviews mention issues with repetitive form-filling and a less prominent login entry point, indicating potential friction in the user experience.

AgileMD's eCARTv5 is an FDA-cleared SaMD that continuously assesses and predicts the risk of clinical deterioration in hospitalized adult patients with high accuracy, validated retrospectively and prospectively across diverse patient demographics and conditions. It provides early warning alerts and embedded clinical pathways, leading to timely intervention and improved patient outcomes. UpDoc is also FDA-cleared and focuses on chronic disease management with physician-governed AI actions, but its primary FDA clearance is for insulin management in Type 2 Diabetes, a more specific use case compared to eCART's all-cause deterioration prediction.

UpDoc offers transparent tiered subscription pricing, including options for unlimited medical certificates, consults, and even weight loss consultations, with clear monthly costs. AgileMD, on the other hand, requires prospective customers to contact the vendor for a tailored quote, making its pricing less transparent. While both offer value, UpDoc's clear pricing structure provides more immediate understanding of cost.

Both tools demonstrate strong enterprise readiness. AgileMD's eCART is deployed in over 400 hospitals with over 150,000 clinical users and integrates seamlessly with EHRs, offering SOC-II and HIPAA compliance. UpDoc is also enterprise-ready, integrates with EHRs and workflows, is HIPAA, SOC2, and GDPR compliant, and has initial deployments at major health systems like Cleveland Clinic and UCSF Health.

UpDoc Inc. stands out for its innovative 'agentic clinical AI platform' that deploys AI agents for continuous, physician-governed care-related tasks, particularly in chronic disease management. It has also achieved FDA clearance for a patient-facing large language model, a significant regulatory milestone. AgileMD's eCARTv5, while highly effective and AI-powered for clinical deterioration prediction, represents an advancement in early warning systems rather than a fundamentally new paradigm in AI interaction.

AgileMD provides extensive documentation through numerous peer-reviewed publications (85+ medical journal publications) and offers training resources. UpDoc's documentation and support are less explicitly detailed in the provided information, with some user reviews mentioning ambiguous customer service experiences and difficulty canceling subscriptions.